Allowing Medicare to cover popular weight loss drugs such as Wegovy and Zepbound could increase federal spending by billions ...

Expanding Medicare to cover weight loss drugs would cost $35 billion over eight years, according to a new report from the ...

Medicare coverage of weight loss drugs, if authorized, is seen increasing federal spending by about $35B from 2026 to 2034.

Medicare is prohibited by law from covering GLP-1 drugs for weight loss. But many beneficiaries can access the drugs anyway.

According to the Congressional Budget Office, the average 2034 per-user effect could be $650 in savings and $4,300 in costs ...

Expanding coverage of weight-loss drugs like blockbusters from Eli Lilly & Co. and Novo Nordisk A/S would make 12.5 million ...

Authorizing Medicare to cover weight loss drugs would increase federal spending by about $35 billion from 2026 to 2034 ...

Covering anti-obesity drugs in the US Medicare program would increase federal spending by about $35 billion over nine years, ...

The Centers for Medicare and Medicaid Services (CMS) just shared a preliminary list of generic drugs it plans to make ...

As the leaves start to turn and the air gets a little crisper, it’s also time to make some important healthcare ...

As that figure was large, weight loss drug producer Eli Lilly (NYSE: LLY) saw a nearly 2% bump in its share price in response ...

Just like when you find a glitzy resort in your dream destination, your first question about weight loss drugs might be, how ...